Claims for Patent: 4,195,127

Summary for Patent: 4,195,127

Title:	Process for immobilizing proteins
Abstract:	A protein which can be an enzyme is immobilized by: (a) admixing the protein and an isocyanate-capped liquid polyurethane prepolymer to form an intermediate product; and (b) foaming the intermediate product by reacting it with water to form a polyurethane foam comprising the immobilized enzyme.
Inventor(s):	Hartdegen; Frank J. (Columbia, MD), Swann; Wayne E. (Pasadena, MD)
Assignee:	W. R. Grace & Co. (New York, NY)
Application Number:	05/851,932
Patent Claims:	1. A solution prepared by admixing, in the absence of water, an isocyanate-capped liquid polyurethane prepolymer and a protein, wherein said prepolymer is the reaction product of a polyether polyol with sufficient polyisocyanate to provide at least two free NCO groups per molecule of the prepolymer. 2. The solution of claim 1 in which the isocyanate-capped liquid polyurethane prepolymer is prepared by reacting toluene diisocyanate and a polyethylene glycol. 3. The solution of claim 1 in which the isocyanate-capped liquid polyurethane prepolymer is prepared by reacting toluene diisocyanate and a polyethylene glycol having a molecular weight (average molecular weight) of about 1,000. 4. The solution of claim 1 in which the isocyanate-capped liquid polyurethane prepolymer is prepared by reacting toluene diisocyanate and a member selected from the group consisting of a polyoxybutylene polyol polymer, ethylene glycol, diethylene glycol, a polyoxyethylene polyol polymer, pentaerythritol, glycerol, trimethylolpropane, and a polyoxypropylene polyol polymer. 5. The solution of claim 1 in which the isocyanate-capped liquid polyurethane prepolymer is prepared by reacting toluene diisocyanate with an admixture of a polyethylene glycol having a molecular weight of about 800-1200 and trimethylolpropane, the trimethylolpropane and the polyethylene glycol being provided in a mole ratio of about 1:1-4 and the toluene diisocyanate being provided at a rate of about 0.85-1.25 mole per equivalent of --OH provided by the polyethylene glycol plus the trimethylolpropane. 6. The solution of claim 1 in which the protein is an enzyme, an antibody, or an antigen. 7. The solution of claim 6 in which the enzyme is urease, trypsin, lactase, glucose oxidase, chymotrypsin, ribonuclease, peroxidase, pepsin, rennin, invertase, papain, asparaginase, pectinase, pectin esterase, penicillin amidase, glucose isomerase, lysozyme, amino acid acylase, pronase, alcohol dehydrogenase, .alpha.-amylase, .beta.-amylase, subtilisin, amino acid oxidase, catalase, tannase, phenol oxidase, glucoamylase, pullulanase, cellulase, ficin, bromelain, pancreatin, isoamylase, lipase, malic dehydrogenase, hexokinase, lactate dehydrogenase, adenosine deaminase, uricase, galactose oxides, diaphorase, cholinesterase, aldolase, pyruvate carboxylase, phospharylase, cephalosporin amidase, isocitric dehydrogenase, .alpha.-glycerolphosphate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, malic enzyme, glucose-6-phosphate dehydrogenase, 5-dehydroshikimic reductase, glutathione reductase, glycolic acid oxidase, yeast cytochrome c reductase, luciferase, nitrite reductase, glutamyl transferase, glutathione synthetase, glycocyamine phosphokinase, hippuric acid synthetase, aldehyde oxidase, succinic dehydrogenase, nitrate reductase, xanthine oxidase, lipoyl dehydrogenase, flavin peroxidase, glycine oxidase, carboxylase, .alpha.-keto acid dehydrogenase, or transketolase. 8. The solution of claim 6 in which the antigen is human immunoglobulin G. 9. The solution of claim 6 in which the antibody is hepatitis antibody.. 10. A process for dissolving a protein comprising admixing the protein with an isocyanate-capped liquid polyurethane prepolymer in the absence of water, wherein said prepolymer is the reaction product of a polyether polyol with sufficient polyisocyanate to provide at least two free NCO groups per molecule of the prepolymer. 11. The process of claim 10 in which the protein is an enzyme, an antibody, or an antigen.

Details for Patent 4,195,127

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		1996-02-24
Csl Behring Ag	CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN	immune globulin intravenous (human)	For Injection	102367	07/27/2000		1996-02-24
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	07/26/2007		1996-02-24
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	10/02/2009		1996-02-24
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	02/07/2013		1996-02-24
Bio Products Laboratory	GAMMAPLEX	immune globulin intravenous (human)	Injection	125329	09/17/2009		1996-02-24
Bio Products Laboratory	GAMMAPLEX	immune globulin intravenous (human)	Injection	125329	02/06/2017		1996-02-24